MU School of Medicine Receives Grant for Alzheimer's Research

A newly announced research grant will allow scientists at the University of Missouri School of Medicine to expand a long-running study into the earliest biological signs of Alzheimer's disease, work researchers hope will eventually help identify at-risk patients years before symptoms become noticeable. The funding supports a multi-year effort combining brain imaging, blood-based biomarkers, and cognitive testing among a growing group of aging study participants across mid-Missouri.

Alzheimer's disease and related dementias remain among the most significant public health challenges facing Missouri's aging population, with cases expected to rise as the state's older adult population continues to grow over the coming decades. Researchers say early detection remains one of the field's biggest unmet needs, since by the time most patients show clear symptoms, underlying brain changes have often been progressing for years.

Looking for Signals Before Symptoms

The expanded study will track cognitively healthy older adults over time, using periodic brain scans and blood tests to look for subtle biological changes that may precede clinical symptoms of memory loss or cognitive decline. Researchers hope that identifying reliable early biomarkers could eventually allow physicians to intervene sooner, whether through lifestyle interventions, closer monitoring, or emerging treatments designed to slow disease progression.

"By the time someone is showing clear signs of memory loss, we're often already working with a brain that has undergone significant changes," said a neurology researcher involved in the study. "If we can find reliable markers years earlier, that opens the door to intervention at a point when it may do more good."

Recruiting Missouri Participants

A key part of the grant supports expanded recruitment of study participants from across mid-Missouri, including rural counties that have historically been underrepresented in major medical research studies. Researchers say building a more geographically and demographically diverse participant pool is essential, since Alzheimer's research has often relied on relatively homogenous study populations that may not reflect the full range of patients affected by the disease.

A research coordinator working on participant recruitment said building relationships with rural community organizations, senior centers, and primary care clinics has been central to the effort. "We want this research to actually reflect the population it's meant to help," she said. "That means making participation accessible for people who don't live anywhere near a major medical campus."

A Long-Term Commitment

Researchers caution that meaningful findings from longitudinal studies like this one typically take years, if not decades, to fully materialize, since tracking biological changes over time requires sustained participant engagement and repeated testing. The grant provides funding to support the next several years of the project, though researchers note that continued funding beyond that period will depend on demonstrating measurable scientific progress.

University officials describe the investment as part of a broader commitment to positioning Missouri as a contributor to national Alzheimer's research rather than solely relying on findings generated elsewhere. As the state's older adult population continues to grow, researchers say work like this will only become more relevant to families across Missouri who are already navigating the challenges of caring for a loved one with cognitive decline.